Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Betterlife Pharma Inc (BETRF)

Betterlife Pharma Inc (BETRF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 9,334
  • Shares Outstanding, K 129,463
  • Annual Sales, $ 0 K
  • Annual Income, $ -2,140 K
  • EBIT $ -4 M
  • EBITDA $ -4 M
  • 60-Month Beta 1.27
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.03
  • Most Recent Earnings $-0.01 on 09/25/24
  • Next Earnings Date 01/03/25
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0713 +1.12%
on 11/15/24
0.1000 -27.90%
on 10/22/24
-0.0031 (-4.12%)
since 10/18/24
3-Month
0.0580 +24.31%
on 10/16/24
0.1421 -49.26%
on 08/29/24
-0.0067 (-8.50%)
since 08/20/24
52-Week
0.0309 +133.33%
on 12/14/23
0.1500 -51.93%
on 07/11/24
+0.0282 (+64.24%)
since 11/20/23

Most Recent Stories

More News
BetterLife Obtains Favourable Genotoxicity Data for Oral BETR-001

BETR.CN : 0.1200 (+14.29%)
BETRF : 0.0721 (unch)
BetterLife Pharma Inc. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

Vancouver, British Columbia--(Newsfile Corp. - April 15, 2024) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF), an emerging biotech company focused on the development and commercialization of cutting-edge...

BETRF : 0.0721 (unch)
BETR.CN : 0.1200 (+14.29%)
BetterLife Pharma to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference

Vancouver, British Columbia--(Newsfile Corp. - April 24, 2023) - BetterLife Pharma (CSE: BETR), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for...

BETRF : 0.0721 (unch)
BETR.CN : 0.1200 (+14.29%)
BetterLife To Participate at the H.C. Wainwright 1st Annual Mental Health Conference

VANCOUVER, British Columbia, June 23, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA:...

BETR.CN : 0.1200 (+14.29%)
BETRF : 0.0721 (unch)
BetterLife To Present BETR-001 Preclinical Data at the Upcoming Canadian Association for Neuroscience Conference

VANCOUVER, British Columbia, April 21, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA:...

BETR.CN : 0.1200 (+14.29%)
BETRF : 0.0721 (unch)
BetterLife Obtains In Vivo PK Data for BETR-001 Confirming its Bioavailability in Brain

VANCOUVER, British Columbia, March 16, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA:...

BETR.CN : 0.1200 (+14.29%)
BETRF : 0.0721 (unch)
BetterLife Launches New Corporate Website

VANCOUVER, British Columbia, Feb. 10, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR/ OTCQB: BETRF/ FRA:...

BETR.CN : 0.1200 (+14.29%)
BETRF : 0.0721 (unch)
BetterLife Obtains Positive In Vivo Oral Bioavailability, Food Effect and Pharmacokinetics Data for BETR-001

VANCOUVER, British Columbia, Jan. 18, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA:...

BETR.CN : 0.1200 (+14.29%)
BETRF : 0.0721 (unch)
Dr. Eleanor Fish, Advisory Board Member, Awarded Order of Canada

VANCOUVER, British Columbia, Jan. 06, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA:...

BETR.CN : 0.1200 (+14.29%)
BETRF : 0.0721 (unch)
BetterLife’s Wholly-Owned Subsidiary, Altum Pharmaceuticals, Obtains Non-Dilutive Financing Commitment From Strategic Investor!

VANCOUVER, British Columbia, Dec. 22, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA:...

BETR.CN : 0.1200 (+14.29%)
BETRF : 0.0721 (unch)

Business Summary

BetterLife Pharma Inc. is a science-based medical wellness company. It developed pharmaceutical grade products including CBD, phytocannabinoid and micronutrient derived formulations utilizing proprietary drug delivery technologies. BetterLife Pharma Inc., formerly known as Pivot Pharmaceuticals Inc.,...

See More

Key Turning Points

3rd Resistance Point 0.0833
2nd Resistance Point 0.0810
1st Resistance Point 0.0766
Last Price 0.0721
1st Support Level 0.0699
2nd Support Level 0.0676
3rd Support Level 0.0632

See More

52-Week High 0.1500
Fibonacci 61.8% 0.1045
Fibonacci 50% 0.0905
Fibonacci 38.2% 0.0764
Last Price 0.0721
52-Week Low 0.0309

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar